A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA) (clinicaltrials.gov) - Sep 20, 2024 - P2 | N=24 | Active, not recruiting | Sponsor: Kezar Life Sciences, Inc. | Trial completion date: Mar 2025 ➔ Aug 2025 | Trial primary completion date: Sep 2024 ➔ Feb 2025
Trial completion date • Trial primary completion date • Autoimmune Hepatitis • Hepatology • Immunology • Inflammation
|